AOD-9604 5mg is a modified HGH fragment research peptide studied for its role in lipolysis, fat metabolism, and energy regulation pathways. In laboratory settings, AOD-9604 is widely used in research focused on adipose tissue signaling, metabolic efficiency, and fat breakdown models.
For laboratory research use only. Not intended for human or animal consumption.
For Research Use Only. Not for human use.
AOD9604 is a modified analogue of the hGH C-terminal fragment (residues 177–191 with N-terminal tyrosine addition and disulfide cyclisation), first synthesized in the 1990s by Metabolic Pharmaceuticals. It has been studied for its selective stimulation of lipolysis via beta-3 adrenergic receptor upregulation in adipose tissue without elevating IGF-1 or producing hGH-like anabolic side effects. This research-grade lyophilized powder is synthesized under strict quality controls and includes full analytical documentation, making it suitable for metabolic, lipolytic, and cartilage repair research applications.
Key Scientific Features
Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)
Why Researchers Choose Nationwide Peptides AOD9604
| Product Name | AOD-9604 Peptide |
|---|---|
| Avg Purity | ≥99% |
| Chemical Data | CAS: 221231-10-3; Formula: C₇₈H₁₂₃N₂₃O₂₃S₂; Molecular Weight: approximately 1815.1 g/mol |
| Format | Lyophilized freeze-dried peptide powder |
| Quantity | 5mg per vial |
| Packaging | Sealed research vial with batch label, protective carton |
